HemaSphere (Oct 2019)

Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center

  • Jesko Momotow,
  • Helen Goergen,
  • Karolin Behringer,
  • Paul J. Bröckelmann,
  • Sven Borchmann,
  • Bastian v. Tresckow,
  • Carsten Kobe,
  • Andreas Engert,
  • Stephanie Sasse

DOI
https://doi.org/10.1097/HS9.0000000000000293
Journal volume & issue
Vol. 3, no. 5

Abstract

Read online

No abstracts available.